Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 2 Jul, 01:00 am
Roth Capital set a new price target of $13.50 for Silvercorp Metals (AMEX: SVM) , indicating a potential 32.29% upside from its previous trading price. Silvercorp Metals recently filed its Annual Report and updated technical reports, including new mineral reserve estimates for it
Analyst firm CIBC maintained an "Outperform" rating for TFI International (NYSE: TFII) and raised its price target to $172 . The company was added to the Zacks Rank #1 (Strong Buy) List, highlighting its strong investment potential. The Zacks Consensus Estimate for TFI Internatio
Analysts Bullish on Robinhood (NASDAQ: HOOD) Amid Strong Growth Prospects Multiple financial institutions, including Deutsche Bank, Goldman Sachs, Barclays, and BTIG, have issued "Buy" ratings for Robinhood, with price targets ranging from $82.00 to $125.00 . Robinhood's growth i
UnitedHealth Group (NYSE: UNH) is demonstrating stock strength, bolstered by a positive "Overweight" rating and an increased price target from Morgan Stanley. The company's improved financial performance is highlighted by a reduced medical care ratio of 83.9% , signaling effectiv
Grab Holdings (NASDAQ:GRAB) , a leading Southeast Asian super-app, garners strong analyst support, including an "Overweight" rating from Morgan Stanley and a "Strong Buy" consensus. The company demonstrates robust financial performance with 22% revenue growth and an impressive 58
General Mills (NYSE: GIS) Q4 Earnings Preview: Valuation, Strategy, and Analyst Expectations Analysts anticipate strong earnings per share (EPS) growth for General Mills, Inc. (NYSE: GIS), with an expected $0.82 for Q4, representing a 10.8% increase year-over-year. The consumer f
Abivax 's lead drug candidate, obefazimod, demonstrated positive clinical trial results for ulcerative colitis, leading to a significant stock price increase. An analyst from BTIG set a price target of $175.00 for Abivax , indicating a potential 82% upside from its previous tradi
RBC Capital reaffirmed an "Outperform" rating for AeroVironment, despite lowering its stock price target from $250.00 to $210.00 . The company reported strong financial results, with fourth-quarter earnings of $1.84 per share exceeding estimates and revenue more than doubling to
Taiwan Semiconductor Manufacturing Company (NYSE: TSM) maintains a dominant position as a semiconductor industry leader in the global foundry market, controlling over 70% and boasting a market capitalization of approximately $2.36 trillion . The company demonstrates robust stock
Arete Research downgraded The Trade Desk (NASDAQ: TTD) to a Sell rating with a price target of $11.60 . The Trade Desk stock recently hit a new 52-week low of $16.98 , reflecting a 50% year-to-date decline. The company reported a significant slowdown in revenue growth to 12% year
Citigroup maintains a "Buy" rating for Zymeworks , raising its price target to $37 from $35 . Zymeworks is set to acquire Theravance Biopharma in an all-cash transaction valued at approximately $929 million , adding the COPD treatment YUPELRI® to its portfolio. The acquisition is
Robert W. Baird downgraded Alpine Income Property Trust to a "Neutral" rating with a $21.00 price target, despite its shares trading slightly higher at $21.26 . The REIT demonstrates robust operational performance, including an 11% compound annual growth rate in AFFO per share, a
Fortinet (NASDAQ: FTNT) received a "Reduce" rating from HSBC (NYSE: HSBC) with a price target of $102.00 , suggesting a potential 34.37% downside. Despite the downgrade, the cybersecurity stock has shown positive market activity, with a 2.69% gain in the latest session and 9.7% o
Boundless Bio, Inc. (NASDAQ: BOLD) is set to merge with Serapha Bio, Inc., forming a new entity focused on advancing a program for Alpha-1 Antitrypsin Deficiency (AATD) . A significant insider, TANG KEVIN, recently increased their stake in Boundless Bio, Inc., acquiring 63,985 sh
Concentrix reported an earnings per share (EPS) of $2.63 , slightly missing the analyst consensus estimate of $2.64 . Despite a narrow miss on estimates, quarterly revenue grew by 1.9% year-over-year, reaching $2.46 billion . The company maintains sound financial health with a De
Constellation Brands (NYSE:STZ) is navigating challenges from declining alcohol demand and shifting consumer preferences. Analysts forecast a 1.9% increase in earnings per share (EPS) to $3.28 , despite an anticipated 3.9% decrease in revenue to $2.42 billion . Options markets su
Affirm Holdings (NASDAQ:AFRM) Stock Analysis: Analyst Ratings and Market Performance Piper Sandler initiated coverage on Affirm Holdings (NASDAQ:AFRM) with an Overweight rating and a $103.00 price target , indicating a positive investment outlook. The company's shares have demons
Despite an analyst downgrade from HSBC, Fortinet (NASDAQ: FTNT) stock demonstrated strong market resilience, closing at $155.42 and reaching a new 52-week high of $159.04 . The company is strategically expanding its product portfolio, including new FortiGate G Series models with
Headlines provided by Investing.com